Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Report: <i>Vibrio fluvialis</i> isolated from a wound infection after a piercing trauma in the Baltic Sea.

Access microbiology·2022
Same author

Effectiveness of bisoprolol versus other β-blockers and other antihypertensive classes: a cohort study in the Clinical Practice Research Datalink.

Journal of comparative effectiveness research·2022
Same author

Nearly Identical Plasmids Encoding VIM-1 and Mercury Resistance in Enterobacteriaceae from North-Eastern Germany.

Microorganisms·2021
Same author

A Klebsiella pneumoniae ST307 outbreak clone from Germany demonstrates features of extensive drug resistance, hypermucoviscosity, and enhanced iron acquisition.

Genome medicine·2020
Same author

Prediction of Radioresistant Prostate Cancer Based on Differentially Expressed Proteins.

Urologia internationalis·2020
Same author

Chikungunya virus capsid protein contains nuclear import and export signals.

Virology journal·2013

Related Experiment Video

Updated: Jul 13, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Hepatitis B virus genotypes in Europe.

Stephan Schaefer1

  • 1Department of Virology, Institute for Medical Microbiology, Virology and Hygiene, Rostock University, Rostock, Germany.

Hepatology Research : the Official Journal of the Japan Society of Hepatology
|July 14, 2007
PubMed
Summary

Hepatitis B virus (HBV) genotypes A and D show distinct geographic distributions in Europe. Genotype A responds better to interferon treatment, but lamivudine treatment shows more YMDD variants in genotype A.

Area of Science:

  • Hepatology
  • Virology
  • Epidemiology

Background:

  • Hepatitis B virus (HBV) exhibits eight genotypes, often with further subgenotype divisions.
  • HBV genotypes impact disease progression, treatment efficacy, and possess distinct geographic prevalence patterns.
  • In Europe, genotypes A and D are predominant, with genotype A more common in the north and genotype D in Mediterranean and Eastern European regions.

Purpose of the Study:

  • To summarize current knowledge on HBV genotypes and subgenotypes in European countries with low to intermediate HBV endemicity.
  • To review the geographic distribution of HBV genotypes and subgenotypes in Europe.
  • To analyze the influence of HBV genotypes on treatment outcomes, specifically with interferon and lamivudine.

Main Methods:

  • Literature review of existing studies on HBV genotypes in Europe.

More Related Videos

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Related Experiment Videos

Last Updated: Jul 13, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

  • Analysis of geographic prevalence data for HBV genotypes A and D and their subgenotypes.
  • Comparison of treatment responses (virological response, anti-HBs development, YMDD variant emergence) based on HBV genotype.
  • Main Results:

    • Genotype A is prevalent in Northern Europe, while genotype D is found in Southern and Eastern Europe.
    • Subgenotype A2 is the most common subgenotype across Europe.
    • Genotype A demonstrates superior virological response to interferon therapy compared to genotype D, with higher rates of anti-HBs development.
    • Lamivudine treatment in the first year shows increased YMDD variant emergence in genotype A compared to genotype D.

    Conclusions:

    • HBV genotypes A and D exhibit clear geographic segregation in Europe.
    • Genotype A offers a better virological response to interferon but presents a higher risk of YMDD variant emergence with lamivudine.
    • Further research is needed to clarify the geographic prevalence of genotype D subgenotypes.